Monocyte activation in patients with Wegener's granulomatosis.
about
Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture--primary culture cells markedly differ from fourth-passage cellsOverview of the Pathogenesis of ANCA-Associated VasculitisAnti-neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognize restricted epitopes of proteinase 3 involving the catalytic siteManagement of ANCA-associated vasculitis: Current trends and future prospectsA novel mechanism for neutrophil priming in trauma: potential role of peritoneal fluid.Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitisIncreased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients.Upper respiratory tract symptoms, renal involvement and vasculitis: a case report and review of wegener granulomatosis.Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome?Primary human monocyte differentiation regulated by Nigella sativa pressed oil.Anti-neutrophil cytoplasmic autoantibodies: a renewed paradigm in periodontal disease pathogenesis?Relationship between markers of platelet activation and inflammation with disease activity in Wegener's granulomatosis.Highly efficient SERS-based detection of cerebrospinal fluid neopterin as a diagnostic marker of bacterial infection.Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis.Increased expression of FcgammaRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus.Escherichia coli K1 induces pterin production for enhanced expression of Fcγ receptor I to invade RAW 264.7 macrophages.T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease.Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum.A case of Wegener's granulomatosis mimicking recurrent hemophagocytic lymphohistiocytosis.Regulation of myeloperoxidase-specific T cell responses during disease remission in antineutrophil cytoplasmic antibody-associated vasculitis: the role of Treg cells and tryptophan degradation.Anti-proteinase 3 antibodies (c-ANCA) prime CD14-dependent leukocyte activation.Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen.The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders.CD14 expression is increased on monocytes in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis and correlates with the expression of ANCA autoantigens
P2860
Q24792971-56C14933-1DFA-4A3D-8947-1588B2237DD4Q26740456-A371C24B-0677-4590-A89C-20738F8259E2Q28347296-548E95F3-0F85-4638-8256-195D04A3EF1AQ33947599-4B01E2ED-591B-443A-A0A6-68993ECA0B5BQ34001141-15834F4C-0C49-42D5-A619-23FB824553D2Q34018969-B6CD1481-EDB1-4BFF-BB3F-A364CDF9D52EQ34122262-29450A2A-CB21-4522-922C-C8C11E0A18E8Q35015340-43CB0F7A-2B57-4E47-AE85-79B0F22E6555Q35553707-20C71B4E-8BE2-476E-9E2D-45BA31CD6F17Q35609175-48D77E5D-4210-436D-A0EE-52C5F97C2CF6Q35761058-B8711AD0-62EC-477D-BB3F-E0B9102F33FBQ36553578-8F67C3C2-70BF-4097-AEF4-F8C3C18A5051Q36843060-0DF4974F-95C5-4576-B605-24B123448F77Q36924105-6DFE474D-1DA4-4437-A8BC-AF847B831D29Q37170453-C3C6FCC5-71D6-42D8-B7BC-29E00B629DDDQ37207056-EA3B59D6-0058-4877-A156-18A912A816EDQ37624700-026047E2-D72F-46A7-A6B7-5135A08CFE92Q37710764-DC14E3D3-D1F6-4990-8DB1-2192F175BC51Q38227267-2A6892BC-D11F-4E34-8E33-A136F738BB3CQ39013880-C215865A-70B8-4D92-8BFF-83090B8FBF9EQ42582348-DEDA23D3-1160-4291-A05B-B9FA64E60529Q43162050-F376649F-5302-4D8D-A626-C73EDD133B34Q43887874-6F265FEB-4FC2-4E1D-B783-CF9955D864F1Q44899131-7CAF3322-9920-4320-BF78-4A34A2803A2CQ50531937-7494877F-010F-4989-BAD5-92E696713391Q57132096-DED395AF-0886-4999-B60A-5398B21F5FB0
P2860
Monocyte activation in patients with Wegener's granulomatosis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Monocyte activation in patients with Wegener's granulomatosis.
@ast
Monocyte activation in patients with Wegener's granulomatosis.
@en
type
label
Monocyte activation in patients with Wegener's granulomatosis.
@ast
Monocyte activation in patients with Wegener's granulomatosis.
@en
prefLabel
Monocyte activation in patients with Wegener's granulomatosis.
@ast
Monocyte activation in patients with Wegener's granulomatosis.
@en
P2093
P2860
P356
P1476
Monocyte activation in patients with Wegener's granulomatosis.
@en
P2093
Kallenberg CG
Muller Kobold AC
Tervaert JW
P2860
P304
P356
10.1136/ARD.58.4.237
P407
P577
1999-04-01T00:00:00Z